The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by D2 gastrectomy and adjuvant chemotherapy for locally advanced gastric cancer (Neo-CRAG): A randomized, multicenter, phase 3 trial.
 
Rui- Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Hutchison MediPharma; Junshi Pharmaceuticals; Keymed Biosience; MSD; QiLu Pharmaceutical
 
Wei Wang
No Relationships to Disclose
 
Yu-Jing Zhang
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Yong-Xiang Li
No Relationships to Disclose
 
Yan Zhao
No Relationships to Disclose
 
Han Liang
No Relationships to Disclose
 
Jian-Si Chen
No Relationships to Disclose
 
Jin Wan
No Relationships to Disclose
 
Yian Du
No Relationships to Disclose
 
Zhenning Wang
No Relationships to Disclose
 
Ping Zhao
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Yanbing Zhou
No Relationships to Disclose
 
Jing Jin
No Relationships to Disclose
 
Yuan-fang Li
No Relationships to Disclose
 
Zhiwei Zhou
No Relationships to Disclose